Gender differences in medication use and cigarette smoking cessation: Results from the International Tobacco Control Four Country Survey

Nicotine and Tobacco Research

Volumn 17, Issue 4, 2014, Pages 463-472

  Smith, Philip H ^a   Kasza, Karin A ^b   Hyland, Andrew ^b   Fong, Geoffrey T ^c   Borland, Ron ^d   Brady, Kathleen ^e   Carpenter, Matthew J ^e   Hartwell, Karen ^e   Cummings, K Michael ^e   McKee, Sherry A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF WATERLOO   (Canada)

^d CANCER EPIDEMIOLOGY CENTRE   (Australia)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE PATCH; VARENICLINE; BENZAZEPINE DERIVATIVE; NICOTINE; NICOTINIC AGENT; QUINOXALINE DERIVATIVE;

ADULT; ARTICLE; AUSTRALIA; CANADA; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MARRIED PERSON; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING CESSATION; TOBACCO DEPENDENCE; UNITED KINGDOM; UNITED STATES; ADOLESCENT; EPIDEMIOLOGY; GENDER IDENTITY; GREAT BRITAIN; MIDDLE AGED; MOTIVATION; PREVENTION AND CONTROL; PROCEDURES; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AUSTRALIA; BENZAZEPINES; CANADA; FEMALE; GENDER IDENTITY; GREAT BRITAIN; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTIVATION; NICOTINE; NICOTINIC AGONISTS; QUINOXALINES; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; UNITED STATES; VARENICLINE;

EID: 84929159267     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu212     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention. Cigarette smoking among adults-United States, 1991. MMWR. 1993;42:230-233. http://www.cdc.gov/mmwr/preview/mmwrhtml/00020103.htm. Accessed October 17, 2014.
2. Fidler J, Ferguson SG, Brown J, Stapleton J, West R. How does rate of smoking cessation vary by age, gender and social grade? Findings from a population survey in England. Addiction. 2013;108:1680-1685.
3. Glassman AH, Helzer JE, Covey LS, et al. Smoking, smoking cessation, and major depression. JAMA. 1990;264:1546-1549.
4. Jarvis MJ, Cohen JE, Delnevo CD, Giovino GA. Dispelling myths about gender differences in smoking cessation: population data from the USA, Canada and Britain. Tob Control. 2013;22:358-362.
5. Hyland A, Borland R, Li Q, et al. Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006;15(suppl 3):iii83-iii94.
6. Hyland A, Li Q, Bauer JE, Giovino GA, Steger C, Cummings KM. Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res. 2004;6(suppl 3):S363-S369.
7. Hymowitz N, Cummings KM, Hyland A, Lynn WR, Pechacek TF, Hartwell TD. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control. 1997;6(suppl 2):S57.
8. Osler M, Prescott E, Godtfredsen N, Hein HO, Schnohr P. Gender and determinants of smoking cessation: a longitudinal study. Prev Med. 1999;29:57-62.
9. Rose JS, Chassin L, Presson CC, Sherman SJ. Prospective predictors of quit attempts and smoking cessation in young adults. Health Psychol. 1996;15:261-268.
10. Borland R, Partos TR, Cummings KM. Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications. Nicotine Tob Res. 2012;14:1483-1487.
11. Kasza KA, Hyland AJ, Borland R, et al. Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction. 2013;108:193-202.
12. Bohadana A, Nilsson F, Rasmussen T, Martinet Y. Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of baseline smoking behavior. Nicotine Tob Res. 2003;5:111-116.
13. Collins BN, Wileyto EP, Patterson F, et al. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. Nicotine Tob Res. 2004;6:27-37.
14. Kralikova E, Kmetova A, Stepankova L, Zvolska K, Davis R, West R. Fiftytwo-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy. Addiction. 2013;108:1497-1502.
15. Scharf D, Shiffman S. Are there gender differences in smoking cessation, with and without bupropion? Pooled-and meta-analyses of clinical trials of Bupropion SR. Addiction. 2004;99:1462-1469.
16. Wetter DW, Kenford SL, Smith SS, Fiore MC, Jorenby DE, Baker TB. Gender differences in smoking cessation. J Consult Clin Psychol. 1999;67:555.
17. Fiore MC. The new vital sign: assessing and documenting smoking status. JAMA. 1991;266:3183-3184.
18. U.S. Department of Health and Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress. A report of the Surgeon General, 1989. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1989. http://profiles.nlm.nih.gov/NN/B/B/X/S/.
19. Munafò M, Bradburn M, Bowes L, David S. Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. Nicotine Tob Res. 2004;6:769-776.
20. Perkins KA, Scott J. Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine Tob Res. 2008;10:1245-1250.
21. Gonzales D, Jorenby DE, Brandon TH, Arteaga C, Lee TC. Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo. Addiction. 2010;105: 2002-2013.
22. Jorenby DE, Hays JT, Rigotti NA, et al.; Varenicline Phase 3 Study Group. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296: 56-63.
23. Fagan P, Augustson E, Backinger CL, et al. Quit attempts and intention to quit cigarette smoking among young adults in the United States. Am J Public Health. 2007;97:1412-1420.
24. Grøtvedt L, Stavem K. Association between age, gender and reasons for smoking cessation. Scand J Public Health. 2005;33:72-76.
25. McKee SA, O'Malley SS, Salovey P, Krishnan-Sarin S, Mazure CM. Perceived risks and benefits of smoking cessation: gender-specific predictors of motivation and treatment outcome. Addictive Behav. 2005;30: 423-435.
26. Turner LR, Mermelstein R. Motivation and reasons to quit: predictive validity among adolescent smokers. Am J Health Behav. 2004;28:542-550.
27. ITC Project. International Tobacco Control Policy Evaluation Survey (ITC Four Country Survey) Waves 2-8 technical report. Waterloo, Ontario, Canada: University of Waterloo; 2001.
28. Fong GT, Cummings KM, Borland R, et al. The conceptual framework of the international tobacco control (ITC) policy evaluation project. Tob Control. 2006;15(suppl 3):iii3-iii11.
29. ITC Project. International Tobacco Control Policy Evaluation Survey (ITC Four Country Survey) Wave 1 technical report. Waterloo, Canada: University of Waterloo; 2004.
30. Thompson ME, Fong GT, Hammond D, et al. Methods of the International Tobacco Control (ITC) four country survey. Tob Control. 2006;15(suppl 3);iii12-iii18.
31. Liang K, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
32. Hardin JW, Hilbe JM. Generalized Estimating Equations. Boca Raton, FL: Chapman & Hall; 2003.
33. Carpenter MJ, Saladin ME, LaRowe SD, et al. Craving, cue reactivity, and stimulus control among early-stage young smokers: effects of smoking intensity and gender. Nicotine Tob Res. 2014;16:208-215.
34. Saladin ME, Gray KM, Carpenter MJ, LaRowe SD, DeSantis SM, Upadhyaya HP. Gender Differences in Craving and Cue Reactivity to Smoking and Negative Affect/Stress Cues. Am J Addiction. 2012;21: 210-220.
35. Weinberger AH, McKee SA. Gender differences in smoking following an implicit mood induction. Nicotine Tob Res. 2012;14:621-625.
36. Franklin TR, Ehrman R, Lynch KG, et al. Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health. 2008;17:287-292.
37. Mazure CM, Toll B, McKee SA, Wu Ran, O'Malley SS. Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion. Drug Alcohol Depend. 2011;114: 68-72.
38. Cepeda-Benito A, Reynoso JT, Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. J consult clin psychol. 2004;72:712-722.
39. Wetter DW, Fiore MC, Young TB, McClure JB, de Moor CA, Baker TB. Gender differences in response to nicotine replacement therapy: objective and subjective indexes of tobacco withdrawal. Exp Clin Psychopharmacol. 1999;7:135.
40. Pirie PL, Murray DM, Luepker RV. Gender differences in cigarette smoking and quitting in a cohort of young adults. Am. J. Public Health. 1991;81:324-327.